Chargement en cours...
Riociguat use in sickle cell related chronic thromboembolic pulmonary hypertension: A case series
Adults with sickle cell disease can develop pulmonary hypertension from a multitude of etiologies. Classified as WHO Group 5, there are no therapies approved for the treatment of sickle cell disease-pulmonary hypertension. Thromboembolic disease is prevalent in sickle cell disease and can lead to pu...
Enregistré dans:
| Publié dans: | Pulm Circ |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
SAGE Publications
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6083805/ https://ncbi.nlm.nih.gov/pubmed/30033820 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2045894018791802 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|